CAR T-cell therapy shows efficacy for extramedullary ALL – Healio
|
CAR T-cell therapy shows efficacy for extramedullary ALL
Healio SALT LAKE CITY — Activity of anti-CD22 chimeric antigen receptor T-cell therapy occurred among children and young adults with extramedullary acute lymphoblastic leukemia, despite delayed time to optimal response, according to study results presented … |
